Regulatory Pathways of SR Protein Kinases

SR蛋白激酶的调控途径

• 批准号: 8503353
• 负责人: JOSEPH ADAMS
• 金额: $ 31万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-02-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8503353
• 关键词: Active Sites; Affect; Alternative Splicing; Alzheimer' s Disease; Arginine; Ataxia; Binding; Biological; Biological Process; C-terminal; Catalysis; Cell Nucleus; Cell physiology; Cells; Complex; Cytoplasm; Data; Defect; Dipeptides; Disease; Docking; Elements; Enzymes; Family; Funding; Gene Expression; Genes; Genetic Materials; Health; Human; Investigation; Karyopherins; Lobe; Macromolecular Complexes; Malignant Neoplasms; Messenger RNA; Metabolic Diseases; Modeling; Modification; Molecular; Molecular Chaperones; Muscular Dystrophies; Myopathy; N Domain; N-terminal; Neurodegenerative Disorders; Nuclear; Nuclear Matrix-Associated Proteins; Nucleotides; Organism; Parkinsonian Disorders; Pathology; Phosphoric Monoester Hydrolases; Phosphorylation; Phosphorylation Site; Phosphotransferases; Process; Processed Genes; Protein Dephosphorylation; Protein Family; Protein Fragment; Protein Kinase; Protein-Serine-Threonine Kinases; Proteins; Proteome; RNA; RNA Splicing; Regulation; Regulatory Pathway; Role; SAFB gene; Serine; Signal Transduction; Site; Spliced Genes; Spliceosome Assembly Pathway; Spliceosomes; Structure; Substrate Specificity; Translations; Work; acrosome stabilizing factor; bioprocess; feeding; human disease; inorganic phosphate; insight; mRNA Precursor; novel; protein activation; protein function; protein protein interaction; prototype; public health relevance; release factor; scaffold

DESCRIPTION (provided by applicant): Splicing is a co-transcriptional process whereby a single gene can be converted into multiple unique mRNA fragments for enhanced protein diversity. While splicing is integral for normal cellular function in complex organisms, mistakes i splice-selection can be extremely deleterious. In fact, splicing errors are associated with numerous human diseases including muscular dystrophy, Alzheimer's disease, parkinsonism, metabolic disorders, ataxias and cancers. Splicing occurs at the spliceosome, a macromolecular complex that includes both RNA and proteins. In the latter group, SR proteins are essential splicing factors that control where and how the spliceosome assembles on precursor mRNA. SR proteins contain C-terminal domains rich in arginine-serine repeats whose polyphosphorylation controls splice-site selection. The SRPK family of protein kinases phosphorylates these RS domains directing SR proteins into the nucleus for splicing activity. While SRPKs are normally localized to the cytoplasm for this function, they can enter the nucleus under certain conditions further affecting SR protein phosphorylation levels and alternative gene splicing. Although phosphorylation is critical for splice-site choice, very little is known about how residue-specific phosphorylation of SR proteins controls alternative gene splicing. Clearly, knowing how the SRPKs are regulated in the cell and how they recognize and phosphorylate SR proteins is essential for an understanding of gene splicing and disease pathologies related to mis-splicing. We showed that SRPKs and phosphatases work in opposite directions concentrating phosphates toward the C-terminal end of RS domains. We will now explore how this unique phosphate distribution termed "phosphate biasing" affects SR protein function. We recently showed that the catalytic activity of SRPK1 is dependent on a nucleotide release factor composed of sequence elements from a large insert domain and an N-terminal extension. We propose that this conserved release factor is a hub for SRPK regulation in the cell. We will demonstrate how phosphorylation and protein-protein interactions modulate this factor and regulate SR protein phosphorylation levels and gene splicing.

描述（由申请人提供）：剪接是一种共转录过程，其中单个基因可以转化为多个独特的mRNA片段，以增强蛋白质多样性。虽然剪接对于复杂生物体中的正常细胞功能是不可或缺的，但剪接选择中的错误可能是极其有害的。事实上，剪接错误与许多人类疾病相关，包括肌肉萎缩症、阿尔茨海默病、帕金森综合征、代谢紊乱、共济失调和癌症。剪接发生在剪接体上，剪接体是一种包括RNA和蛋白质的大分子复合物。在后一组中，SR蛋白是控制剪接体在前体mRNA上组装的位置和方式的重要剪接因子。SR蛋白含有富含丝氨酸-丝氨酸重复序列的C-末端结构域，其多磷酸化控制剪接位点选择。蛋白激酶的SRPK家族磷酸化这些RS结构域，将SR蛋白引导到细胞核中进行剪接活性。虽然SRPKs通常定位于细胞质以实现此功能，但它们可以在某些条件下进入细胞核，进一步影响SR蛋白磷酸化水平和选择性基因剪接。尽管磷酸化对于剪接位点的选择至关重要，但是对于残基特异性磷酸化是如何影响剪接位点选择的， SR蛋白的磷酸化控制可变基因剪接。显然，了解SRPKs在细胞中的调节方式以及它们如何识别和磷酸化SR蛋白对于理解基因剪接和与错误剪接相关的疾病病理是至关重要的。我们发现，SRPKs和磷酸酶的工作方向相反，集中磷酸盐对C-末端的RS结构域。我们现在将探讨这种独特的磷酸盐分布称为“磷酸盐偏置”如何影响SR蛋白的功能。我们最近发现，SRPK 1的催化活性依赖于核苷酸释放因子组成的序列元素从一个大的插入域和N-末端延伸。我们认为这种保守的释放因子是细胞中SRPK调节的中心。我们将展示如何磷酸化和蛋白质-蛋白质相互作用调节这个因素，并调节SR蛋白磷酸化水平和基因剪接。